- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01695278
A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community (C4C)
19. November 2014 aktualisiert von: Mercedes Carnethon, Northwestern University
Coaching for Control: A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community
Diabetes poses a substantial burden to racial/ethnic minorities and in populations with limited access to healthcare.
However, there is a shortage of healthcare providers available to help patients adopt the lifestyle changes required for diabetes control.
The goal of the present study is to evaluate the feasibility and effectiveness of a diabetes self-care intervention delivered by medical students to patients with poorly controlled diabetes.
Training medical students to use proven communication techniques to help patients identify and overcome barriers to adopting lifestyle changes in diabetes is a novel but plausible strategy.
The investigators anticipate that findings from our pilot study will be used to develop a larger study to definitively test the program's effectiveness.
A long-term benefit of our program is that future healthcare providers are practicing the skills needed to promote positive lifestyle changes and provide care for chronic conditions in diverse communities.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Diabetes and its complications pose a substantial physical, psychological and financial burden on the large number of racial/ethnic minorities and other socioeconomically deprived persons with diabetes.
However, self-management goals are often not met in racial/ethnic minorities and in populations with fewer socioeconomic resources.
In response, our research team has developed a novel "health coaching" intervention to promote diabetes self-management in the community.
Health coaching is based on Control Systems Theory and helps patients to: 1) identify problems in self-care behaviors; 2) create dynamic plans for correcting these issues; and, 3) learn to navigate the complexities of everyday life and to achieve clinically and personally desirable outcomes.
The primary innovation of the present project is that first-year medical students are trained to serve as the health coaches, and are participating in the study Coaching for Control (STU00069506).
The objective of our pilot study is to test whether 20 patients from five Northwestern Medicine primary care practice groups (two in the Austin community, two at Northwestern Memorial Hospital and one at Norwegian American Hospital) enrolled in the "Coaching for Control" intervention experience favorable changes in clinical and behavioral outcomes after 16 weeks as compared with an equal number of patients from those same clinics who are not enrolled in the program.
We will use a non-randomized trial design to carry out the following aims: 1. Determine whether patients with diabetes who participate in the "Coaching for Control" behavioral intervention program (i.e., the intervention arm) have lower hemoglobin A1c (HbA1c) after four months than patients who do not participate in the program (i.e., the control arm).
2. Determine whether diabetes patients in the intervention arm report higher task-related self-efficacy for initiating and maintaining recommended diabetes self-care behaviors than participants in the control arm.
We hypothesize that participants in the intervention arm will have more favorable HbA1c and report higher self-efficacy for diabetes self-care behaviors than participants in the control arm.
Secondary objectives are to test whether these changes persist 8 months after the program ends and to test whether we observe changes in additional clinical measures such as blood pressure, waist circumference, and in self-reported health behaviors such as medication adherence, self-care behaviors, physical activity and diet.
Process evaluations through focus groups and interviews with participants will allow us to refine our intervention.
The translational aspects of our proposal include the application of a proven intervention to promote diabetes self-care in a community setting that includes adults at high risk for diabetes complications.
Findings from the present pilot study will be used to justify expansion of the study to a larger group of community members so that we can carry out a larger randomized trial of efficacy.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
16
Phase
- Phase 3
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Illinois
-
Chicago, Illinois, Vereinigte Staaten, 60611
- Northwestern University
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
18 Jahre und älter (Erwachsene, Älterer Erwachsener)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- age > 18 years old,
- diagnosis of diabetes
- ability to read and understand English,
- access to a personal telephone,
- intent to remain in the medical practice group for at least 1 year,
- intention to remain in the Chicago, IL area or surrounding suburbs for 1 year.
- Ability to read and understand the informed consent.
Exclusion Criteria:
- primary diagnosis of gestational diabetes or type 1 diabetes
- severe mental impairment,
- primary preferred language other than English
- severe comorbidity with a life expectancy of < 1 year
- currently enrolled in another counseling-based diabetes intervention program
- prior participation in the Coaching for Control intervention development in 2012
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Aktiver Komparator: Standard Care
Participants will receive standard care from physicians for monitoring and treating their diabetes.
They are placed on a wait list to receive the intervention.
|
Weekly telephone counseling intervention for 16 weeks, used to identify and overcome barriers to diabetes control and set goals for positive behavioral changes supplemented by monthly group classes on skill development.
|
Experimental: Telephone Counseling
Weekly telephone counseling intervention for 16 weeks, used to identify and overcome barriers to diabetes control and set goals for positive behavioral changes supplemented by monthly group classes on skill development.
|
Weekly telephone counseling intervention for 16 weeks, used to identify and overcome barriers to diabetes control and set goals for positive behavioral changes supplemented by monthly group classes on skill development.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in hemoglobin A1c
Zeitfenster: 16 weeks
|
Changes in hemoglobin A1c between baseline and the end of follow-up will be compared between participants in the intervention arm vs. the control arm.
|
16 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Task related self-efficacy for initiating and maintaining diabetes self-management
Zeitfenster: 16 weeks
|
Determine whether diabetes patients in the intervention arm report higher task-related self-efficacy for initiating and maintaining recommended diabetes self-care behaviors than participants in the wait list control arm.
|
16 weeks
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Diabetes self-management behaviors
Zeitfenster: 16 weeks
|
To describe differences in diabetes self-management behavior in participants in the intervention as compared with the wait list control arm
|
16 weeks
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Ermittler
- Hauptermittler: Mercedes R Carnethon, PhD, Northwestern University
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn
1. September 2012
Primärer Abschluss (Tatsächlich)
1. Januar 2014
Studienabschluss (Tatsächlich)
1. August 2014
Studienanmeldedaten
Zuerst eingereicht
24. September 2012
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
26. September 2012
Zuerst gepostet (Schätzen)
27. September 2012
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
21. November 2014
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
19. November 2014
Zuletzt verifiziert
1. November 2014
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- STU00068025
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Diabetes mellitus, Typ 2
-
SanofiAbgeschlossenDiabetes mellitus Typ 1 – Diabetes mellitus Typ 2Ungarn, Russische Föderation, Deutschland, Polen, Japan, Vereinigte Staaten, Finnland
-
University Hospital Inselspital, BerneAbgeschlossen
-
US Department of Veterans AffairsAmerican Diabetes AssociationAbgeschlossenTyp 2 Diabetes mellitusVereinigte Staaten
-
AstraZenecaRekrutierung
-
Daewoong Pharmaceutical Co. LTD.Noch keine RekrutierungT2DM (Typ-2-Diabetes mellitus)
-
Zhongda HospitalRekrutierungTyp-2-Diabetes mellitus (T2DM)China
-
Newsoara Biopharma Co., Ltd.RekrutierungT2DM (Typ-2-Diabetes mellitus)China
-
Shanghai Golden Leaf MedTec Co. LtdAktiv, nicht rekrutierendTyp-2-Diabetes mellitus (T2DM)China
-
SanofiAbgeschlossen
-
Haisco Pharmaceutical Group Co., Ltd.AbgeschlossenT2DM (Typ-2-Diabetes mellitus)China
Klinische Studien zur Telephone Counseling
-
US Department of Veterans AffairsAbgeschlossenDrogenmissbrauch | Doppelte DiagnoseVereinigte Staaten
-
Temple UniversityUnbekanntSitzende Lebensweise | Zigaretten rauchenVereinigte Staaten
-
Hacettepe UniversityAbgeschlossenTyp 2 DiabetesTruthahn
-
Texas Christian UniversityAktiv, nicht rekrutierendMapping-Ansätze zur Vorbereitung des Implementierungstransfers | Behandlungsbereitschaft und EinführungsprogrammVereinigte Staaten
-
Makerere UniversityMinistry of Health, Uganda; Rakai Health Sciences ProjectAktiv, nicht rekrutierend
-
University of California, San DiegoKenya Ministry of Health; Population Council KenyaRekrutierungGewalt in der Partnerschaft | Reproduktiver ZwangKenia
-
University of California, Los AngelesUniversity of California, San Diego; California HIV/AIDS Research Program; Los... und andere MitarbeiterAbgeschlossenHIV-PräventionVereinigte Staaten
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Aurora Health Care; Dean Health System; Mercy Health...AbgeschlossenRauchen | Raucherentwöhnung | Nikotinabhängigkeit | Motivation | AdhärenzVereinigte Staaten